Mehta Piyush sold 200,000 shares of Genpact LTD at $43.05 for −$8.61M on Nov 10, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Senior Vice President and CHRO
Senior Vice President and CHRO
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$8,609,000Shares × reported price
Shares traded
200,000Common Shares
Price per share
$43.05Reported price. Read footnotes for ranges.
% of reported position traded
56.05%This security and ownership context
Holdings after
156,823Direct
Trade date
Nov 10, 2026Sell
Filed
Nov 13, 2026, 4:25 PM ET3-day reporting delay
Accession
0001408238-26-000011Code S · Transaction 400690
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 356,823 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

G price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
G · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −21%1w ago −14%1d ago −14%
Returns since7d30d90d180d1y

Footnotes in full

F1: Includes 338 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on March 12, 2026. The reporting person currently holds a total of 10,850 shares under the ESPP. F2: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.85 to $43.215. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3: The option vested 50% on January 10, 2022 and the remainder on January 10, 2024.